selected scholarly activity
-
conferences
- Treatment of Mice with ApoAl Protects Them Against Doxorubicin Induced Cardiotoxicity in a Scavenger Receptor Class B Type I Dependent Manner. Arteriosclerosis, Thrombosis and Vascular Biology. 2019
- Cardioprotective Effects of Interleukin-15 in Immortalized Human Ventricular Cardiomyocytes. Circulation Research. 2015
- Increasing in vivo Apoa1/HDL Levels Negates the Cardiotoxic Effects of Doxorubicin, and Involves Signalling Through SR-BI, PI3K, and AKT1. Circulation Research. 2015
- 524 Scavenger Receptor Class B Type I Protects Against Doxorubicin Induced Cardiomyocyte Apoptosis. Canadian Journal of Cardiology. S294-S294. 2012
-
journal articles
- High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity. Frontiers in Cardiovascular Medicine. 7:65. 2020
- Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner. American Journal of Physiology. Heart and Circulatory Physiology. 316:H1447-H1457. 2019
- High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2. Biochemical Journal. 475:1253-1265. 2018
- HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner. American Journal of Physiology. Heart and Circulatory Physiology. 314:H31-H44. 2018
- Abstract 18: Increasing in vivo Apoa1/HDL Levels Negates the Cardiotoxic Effects of Doxorubicin, and Involves Signalling Through SR-BI, PI3K, and AKT1. Circulation Research. 117. 2015
- Abstract 415: Cardioprotective Effects of Interleukin-15 in Immortalized Human Ventricular Cardiomyocytes. Circulation Research. 117. 2015
- Abstract 428: Scavenger Receptor Class B Type I Is Required for Protection by High-Density Lipoprotein Against Doxorubicin-Induced Apoptosis in Both Mouse and Human Cardiomyocytes and Cardiotoxicity in Mice. Arteriosclerosis, Thrombosis and Vascular Biology. 34. 2014
- SR-BI and Its Adaptor Protein PDZK1 Are Required for HDL-Mediated Protection Against Doxorubicin Induced Cardiomyocyte Apotosis. Canadian Journal of Cardiology. 29:S178-S179. 2013
- AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats. Journal of Hypertension. 30:725-733. 2012
- Activation of AMPâactivated protein kinase (AMPK) causes vasorelaxation in isolated mesenteric arteries of hypertensive and normotensive rats. The FASEB Journal. 25:lb477-lb477. 2011
- Chronic resveratrol treatment alleviates myocardial ischemia injury in a hypertensive model. The FASEB Journal. 25. 2011
- Improved endothelium dependent vasomotor function in spontaneously hypertensive rats following chronic treatment with resveratrol. The FASEB Journal. 25. 2011
- Implementing a Near Peer Instructor Placement Model in Physiotherapy Education. Physiotherapy Canada. Physiotherapie Canada.
-
posters
-
theses